EB
EBOS Group Limited
EBOSY · OTC
$23.30 +3.15% (+$0.71)
1M -10.73%
Market Cap $1.68B
P/E Ratio 7.62x
Div. Yield 6.16%
ROE 8.23%
Bulios Fair Price
$28.96
24.3% upside
Current Price
$23.3
Undervalued Fair Value Overvalued
According to Bulios Fair Price, EBOSY is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
5/9Valuation
94 /100
Cheap P/E 7.62x
EV/EBITDA 6.11x
PEG 2.56x
Growth
16 /100
Declining EPS growth 6.99%
Rev. growth 2.51%
Book val. growth 4.10%
Profitability
12 /100
Weak Gross margin 7.09%
Net margin 1.67%
FCF margin 1.61%
Quality
42 /100
Average ROIC 5.50%
ROE 8.23%
Asset turnover 1.69x
Debt
50 /100
Moderate Debt/Equity 0.69x
Current ratio 1.16x
Net debt/EBITDA 3.03x
Stability
74 /100
Stable Beta 0.16x
Rev. volatility 8.66%
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about EBOSY
Online
Sector
Healthcare
Industry
Medical - Distribution
CEO
Adam Luke Hall
Employees
5,700
Headquarters
Docklands